Microbiology & Virology
Read More about this categoryShow Less
Microbiology & Virology
A virus is a small infectious agent that replicates inside living cells. Viruses cause many human diseases from small illnesses, like influenza, to more deadly diseases, like hepatitis B and HIV. Our body’s immune system defends against viral infection by generating specific antibodies to bind to and neutralize viral particles and by cell mediated immunity that destroys infected host cells.
Research Areas
- Antibiotic(647)
- CCR5(2)
- CMV(29)
- gp120/CD4(4)
- HBV(87)
- HCV(143)
- HIV(402)
- HSV(101)
- Influenza virus(151)
- NA(7)
- Reverse Transcriptase(70)
- RSV(41)
- SRPK(6)
- SARS-CoV(177)
- Antifungal(46)
- Orthopoxvirus(4)
- Antimalaria(6)
- Beta-Lactamase(3)
- VEEV(1)
- Arenavirus(10)
- Bacterial(1526)
- Enterovirus(26)
- Filovirus(14)
- Fungal(415)
- Parasite(433)
- Virus Protease(74)
- Chicken Pox & Shingles(1)
- Chikungunya(1)
- Coronaviruses(34)
- Dengue(5)
- DNA & RNA Polymerase Inhibitors(10)
- Entry/Fusion Inhibitors(9)
- Epstein-Barr(1)
- Integrase Inhibitors(5)
- MERS(10)
- Rhinoviruses(3)
- West Nile Virus(1)
- Yellow Fever(2)
- Zika(2)
- COVID-19(41)
- Antiviral(2)
- Measles Virus(1)
Products Related to Microbiology & Virology(3825)
- GP10055hemagglutinin precursor (114-122) amide [Influenza A virus]Purity: >98.00%
Partial antigenic glycoprotein
- GP10068surface antigen (208-215) [Hepatitis B Virus]Purity: >98.00%
Surface antigen used for signs of infection
- GC12615Helioxanthin derivative 5-4-2CAS: 203935-39-1Purity: >99.50%
Das Helioxanthin-Derivat 5-4-2 ist ein Analogon von Helioxanthin und zeigt in HepG2.2.15-Zellen eine signifikante Anti-HBV-AktivitÄt in vitro mit einem EC50-Wert von 0,08 uM.
- GC13722Helioxanthin 8-1CAS: 840529-13-7Purity: >98.00%
Helioxanthin 8-1 ist ein Helioxanthin-Analogon, das in vitro eine signifikante Anti-HBV/HCV/HSV-1/HIV-AktivitÄt mit einem EC50-Wert von >5/10/1,4/15 uM aufweist.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GP10055 | hemagglutinin precursor (114-122) amide [Influenza A virus] | - | >98.00% | |
Partial antigenic glycoprotein | ||||
| GP10068 | surface antigen (208-215) [Hepatitis B Virus] | - | >98.00% | |
Surface antigen used for signs of infection | ||||
| GP10128 | Influenza A virus fragment | - | >98.00% | |
Leu-Lys-Phe-Ala-Phe-Ser-Met-Met | ||||
| GP10138 | hemagglutinin (332-340) [Influenza A virus] | - | >98.00% | |
| GC12057 | Daclatasvir (BMS-790052) | 1214735-16-6 | >98.00% | |
HCV NS5A inhibitor | ||||
| GC10390 | Maribavir | 176161-24-3 | >98.00% | |
Maribavir ist ein potenter Inhibitor der Histon-Phosphorylierung, die in vitro durch Wildtyp-pUL97 katalysiert wird, mit einem IC50 von 3 nM. | ||||
| GC10418 | Helioxanthin | 18920-47-3 | >98.00% | |
novel inhibitor of HBV, HCV and HSV-1 virus | ||||
| GC12615 | Helioxanthin derivative 5-4-2 | 203935-39-1 | >99.50% | |
Das Helioxanthin-Derivat 5-4-2 ist ein Analogon von Helioxanthin und zeigt in HepG2.2.15-Zellen eine signifikante Anti-HBV-AktivitÄt in vitro mit einem EC50-Wert von 0,08 uM. | ||||
| GC13722 | Helioxanthin 8-1 | 840529-13-7 | >98.00% | |
Helioxanthin 8-1 ist ein Helioxanthin-Analogon, das in vitro eine signifikante Anti-HBV/HCV/HSV-1/HIV-AktivitÄt mit einem EC50-Wert von >5/10/1,4/15 uM aufweist. | ||||